A One Year Clinical Trial Assessing the Usefulness and Safety of Inhaled Insulin in Diabetics With COPD

PHASE3TerminatedINTERVENTIONAL
Enrollment

105

Participants

Timeline

Start Date

January 31, 2003

Primary Completion Date

September 30, 2008

Study Completion Date

September 30, 2008

Conditions
Diabetes MellitusChronic Obstructive Pulmonary Disease
Interventions
DRUG

Subcutaneous Insulin

Subcutaneous short-acting insulin with dose adjusted according to premeal blood glucose plus oral antidiabetic agent(s) and/or either once or twice daily doses of either Ultralente or neutral protamine hagedorn (NPH) insulin, or a single bedtime dose of insulin glargine.

DRUG

Inhaled Insulin

Inhaled insulin with dose adjusted according to premeal blood glucose plus oral antidiabetic agent(s) and/or either once or twice daily doses of either Ultralente or NPH insulin, or a single bedtime dose of insulin glargine.

Trial Locations (88)

12205

Pfizer Investigational Site, Albany

12206

Pfizer Investigational Site, Albany

15243

Pfizer Investigational Site, Pittsburgh

22401

Pfizer Investigational Site, Fredericksburg

22408

Pfizer Investigational Site, Fredericksburg

23225

Pfizer Investigational Site, Richmond

23229

Pfizer Investigational Site, Richmond

23235

Pfizer Investigational Site, Richmond

23249

Pfizer Investigational Site, Richmond

25701

Pfizer Investigational Site, Huntington

29303

Pfizer Investigational Site, Spartanburg

29307

Pfizer Investigational Site, Spartanburg

30033

Pfizer Investigational Site, Decatur

32025

Pfizer Investigational Site, Lake City

32608

Pfizer Investigational Site, Gainesville

32626

Pfizer Investigational Site, Chiefland

32720

Pfizer Investigational Site, DeLand

32789

Pfizer Investigational Site, Winter Park

32901

Pfizer Investigational Site, Melbourne

33144

Pfizer Investigational Site, Miami

33401

Pfizer Investigational Site, West Palm Beach

33756

Pfizer Investigational Site, Clearwater

33765

Pfizer Investigational Site, Clearwater

37203

Pfizer Investigational Site, Nashville

38119

Pfizer Investigational Site, Memphis

41460

Pfizer Investigational Site, Neuss

42431

Pfizer Investigational Site, Madisonville

43608

Pfizer Investigational Site, Toledo

45231

Pfizer Investigational Site, Cincinnati

45242

Pfizer Investigational Site, Cincinnati

46250

Pfizer Investigational Site, Indianapolis

50314

Pfizer Investigational Site, Des Moines

53705

Pfizer Investigational Site, Madison

59701

Pfizer Investigational Site, Butte

60607

Pfizer Investigational Site, Chicago

61761

Pfizer Investigational Site, Normal

63141

Pfizer Investigational Site, St Louis

64106

Pfizer Investigational Site, Kansas City

67203

Pfizer Investigational Site, Wichita

68105

Pfizer Investigational Site, Omaha

70119

Pfizer Investigational Site, New Orleans

72143

Pfizer Investigational Site, Searcy

72401

Pfizer Investigational Site, Jonesboro

73103

Pfizer Investigational Site, Oklahoma City

75231

Pfizer Investigational Site, Dallas

77030

Pfizer Investigational Site, Houston

77701

Pfizer Investigational Site, Beaumont

77706

Pfizer Investigational Site, Beaumont

78229

Pfizer Investigational Site, San Antonio

78237

Pfizer Investigational Site, San Antonio

80209

Pfizer Investigational Site, Denver

85004

Pfizer Investigational Site, Phoenix

85006

Pfizer Investigational Site, Phoenix

85016

Pfizer Investigational Site, Phoenix

85306

Pfizer Investigational Site, Glendale

85381

Pfizer Investigational Site, Peoria

85715

Pfizer Investigational Site, Tucson

89015

Pfizer Investigational Site, Henderson

89103

Pfizer Investigational Site, Las Vegas

89128

Pfizer Investigational Site, Las Vegas

90073

Pfizer Investigational Site, Los Angeles

92506

Pfizer Investigational Site, Riverside

92648

Pfizer Investigational Site, Huntington Beach

92780

Pfizer Investigational Site, Tustin

93720

Pfizer Investigational Site, Fresno

94705

Pfizer Investigational Site, Berkeley

94904

Pfizer Investigational Site, Greenbrae

96813

Pfizer Investigational Site, Honolulu

96814

Pfizer Investigational Site, Honululu

97219

Pfizer Investigational Site, Portland

97504

Pfizer Investigational Site, Medford

99202

Pfizer Investigational Site, Spokane

99204

Pfizer Investigational Site, Spokane

06708

Pfizer Investigational Site, Waterbury

47713-1227

Pfizer Investigational Site, Evansville

01103

Pfizer Investigational Site, Springfield

01107

Pfizer Investigational Site, Springfield

02453

Pfizer Investigational Site, Waltham

90035-170

Pfizer Investigational Site, Porto Alegre

13083-900

Pfizer Investigational Site, Campinas

01244-030

Pfizer Investigational Site, São Paulo

04231-030

Pfizer Investigational Site, São Paulo

T5J 3N4

Pfizer Investigational Site, Edmonton

T4N 6V7

Pfizer Investigational Site, Red Deer

L7M 4Y1

Pfizer Investigational Site, Burlington

H7T 2P5

Pfizer Investigational Site, Laval

J1H 5N4

Pfizer Investigational Site, Sherbrooke

Unknown

Pfizer Investigational Site, San José

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Pfizer

INDUSTRY

NCT00138671 - A One Year Clinical Trial Assessing the Usefulness and Safety of Inhaled Insulin in Diabetics With COPD | Biotech Hunter | Biotech Hunter